Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334124A2 Diastereomeric peptides and pharmaceutical compositions comprising them
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334115A1 Phenanthridine derivatives and antitumoral medicaments containing phenanthridine
08/13/2003EP1334114A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1333866A1 Polymer based radionuclide containing particulate material
08/13/2003EP1333865A1 Inorganic low density radionuclide coated particles
08/13/2003EP1333864A1 Low density radionuclide-containing particulate material
08/13/2003EP1333861A2 Using heat shock proteins to increase immune response
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333847A1 Combination preparation of a biological response modidier and an anticancer agent and uses thereof
08/13/2003EP1333844A2 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333822A2 Treatment of diseases with adamantane derivatives
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333820A2 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
08/13/2003EP1333811A1 Liposomal formulation of mitoxantrone
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP1143981A4 Treatment and prevention of hiv and other viral infections
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0927179B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
08/13/2003EP0910380B1 Substituted benzylidene indenyl formamides, acetamides and propionamides
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436245A Lipopolysaccharides (LPS) extracted from Escherichia coli
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436236A Gasci基因 Gasci gene
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436233A Methods and compositions based on VEGF antisense oligonucleotides
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436193A Antitumoral ecteinascidin derivs
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436179A Oxadiazole derivs. having anticancer effects
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435419A Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof
08/13/2003CN1435254A Anticancer medicine contg. slime bacteria sporocarp and preparing process thereof
08/13/2003CN1435236A Chinese medicine pill for treating cancer and viral hepatitis and producing process thereof
08/13/2003CN1435232A ÔÇ£KesaiÔÇØ potus for treating malignant tumor
08/13/2003CN1435231A Medicine for treating brain tumor
08/13/2003CN1435229A ÔÇ£ErbeimuÔÇØ capsule preparing process thereof
08/13/2003CN1435208A Anticancer tea bag and producing process thereof
08/13/2003CN1435179A Biologic converted ginseng composition and preparing process thereof
08/13/2003CN1435167A Carboplatin precursor liposome injection and preparing process thereof
08/13/2003CN1117763C Anti-alphaV-integrin monoclonal antibody
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117759C Steroid, its preparation method, medicine composition and use thereof
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605713 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605703 Deletion of the Hck binding region in the IL-6 receptor
08/12/2003US6605645 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605599 Epothilone derivatives
08/12/2003US6605596 Indolocarbazole anticancer agents and methods of using them
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 2211